-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MzXib8rxDAzQPU41pFc5PcO3a7BcuaVLOkDlhDRtESKHnHolGavpCQ089HEM5yPu uT+BbRWO0w2CX5ghZMt0+Q== 0000200406-09-000111.txt : 20091002 0000200406-09-000111.hdr.sgml : 20091002 20091002125734 ACCESSION NUMBER: 0000200406-09-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090930 FILED AS OF DATE: 20091002 DATE AS OF CHANGE: 20091002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foster-Cheek Kaye I CENTRAL INDEX KEY: 0001312622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 091101304 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0209 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-09-30 0000200406 JOHNSON & JOHNSON JNJ 0001312622 Foster-Cheek Kaye I JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 1 0 0 VP, Human Resources Common 4429 D Common 2009-09-30 5 J 0 9 A 1139 I Johnson & Johnson Stock Fund under the 401(k) Savings Plan Common 33 I ESOP under the 401(k) Savings Plan Phantom Stock Units 2009-09-30 4 A 0 48 0 A Common Stock 48 5953 D Includes shares acquired under Issuer's Dividend Reinvestment Program. Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009). Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009). The Phantom Stock converts into common stock on a one-for-one basis. Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2009 at $61.15 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. Linda King, as Attorney-in-Fact for Kaye I. Foster-Cheek 2009-10-02 -----END PRIVACY-ENHANCED MESSAGE-----